Advertisement
Screener

Aurinia Pharmaceuticals Inc. (AUPH) Material Contracts

Aurinia Pharmaceuticals Inc. Material Contracts

Every material contract the company filed as Exhibit 10 (executive pay plans, credit agreements, supplier and indemnity agreements), newest first, with the filing's own description.

  • 2026-04-03: Form 8-K; Exhibit 10.1; Description Form of Tender and Support Agreement, dated as of March 30, 2026, by and among Aurinia Pharma U.S., Inc., Aurinia Merger Sub, Inc., Kezar Life Sciences, Inc. and the stockholders party thereto..
  • 2023-09-21: Form 8-K; Exhibit 10.1; Description Cooperation Agreement, dated as of September 21, 2023, by and among MKT Capital Ltd., MKT Tactical Fund, SP, Antoine Khalife and Aurinia Pharmaceuticals Inc..
  • 2023-02-28: Form 10-K; Exhibit 10.21; Description EX-10.21 FORM OF RESTRICTED STOCK UNIT AWARD.
  • 2023-02-28: Form 10-K; Exhibit 10.20; Description EX-10.20 FORM OF INDUCEMENT RESTRICTED STOCK UNIT AWARD.
FiledFormExhibitDescription
2026-04-038-K10.1Form of Tender and Support Agreement, dated as of March 30, 2026, by and among Aurinia Pharma U.S., Inc., Aurinia Merger Sub, Inc., Kezar Life Sciences, Inc. and the stockholders party thereto.
2023-09-218-K10.1Cooperation Agreement, dated as of September 21, 2023, by and among MKT Capital Ltd., MKT Tactical Fund, SP, Antoine Khalife and Aurinia Pharmaceuticals Inc.
2023-02-2810-K10.21EX-10.21 FORM OF RESTRICTED STOCK UNIT AWARD
2023-02-2810-K10.20EX-10.20 FORM OF INDUCEMENT RESTRICTED STOCK UNIT AWARD
2022-11-0310-Q10.26Separation Agreement between Aurinia Pharmaceuticals Inc. and Rob Huizinga dated October 20, 2022
2022-11-0310-Q10.25Separation Agreement between Aurinia Pharmaceuticals Inc. and Neil Solomons dated October 20, 2022
2022-11-0310-Q10.24Separation Agreement between Aurinia Pharma U.S. Inc. and Max Colao dated August 12, 2022
2022-08-0410-Q10.46Supply Agreement by and between Aurinia Pharmaceuticals Inc. and Otsuka Pharmaceutical Co. Ltd. dated August 1, 2022
2022-08-0410-Q10.23Employment Agreement between Aurinia Pharma U.S. Inc., and Scott Habig dated June 27, 2022
2022-08-0410-Q10.22Employment Agreement between Aurinia Pharma U.S. Inc., and Volker Knappertz, M.D., dated July 11, 2022
2021-02-2410-K10.20Form of Inducement Grant Option Commitment
2021-02-2410-K10.19Separation Agreement between Aurinia Pharma U.S., Inc. and Erik Eglite dated October 26, 2020
2021-02-2410-K10.18Employment Agreement between the Registrant and Neil Solomons dated October 1, 2017
2021-02-2410-K10.17Employment Agreement between the Registrant and Stephen Robertson dated September 29, 2020
2021-02-2410-K10.16Employment Agreement between Aurinia Pharma U.S. Inc. and Joe Miller dated April 8, 2020
2021-02-2410-K10.15Employment Agreement between the Registrant and Michael Martin dated October 1, 2017
2021-02-2410-K10.14Employment Agreement between the Registrant and Robert Huizinga dated October 1, 2017
2021-02-2410-K10.13Employment Agreement between Aurinia Pharma U.S. Inc. and Max Donley dated July 15, 2019
2021-02-2410-K10.12Employment Agreement between Aurinia Pharma U.S. Inc. and Max Colao dated February 10, 2020
2021-02-2410-K10.11Employment Agreement between Aurinia Pharma U.S., Inc. and Peter Greenleaf dated April 11, 2019
2021-02-2410-K10.10Settlement Agreement among ILJIN Life Science Co. Ltd., Isotechnika Pharma Inc., and Aurinia Pharmaceuticals Inc., dated April 3, 2013
2021-02-2410-K10.9Softgel Commercial Supply Agreement between the Registrant and Catalent Pharma Solutions, LLC dated August 28, 2020
2021-02-2410-K10.8Lease agreement for space at Suite No. 1203 and No. 1201 Building No. 100, 4464 Markham Street Victoria, BC between University of Victoria Properties Investments, Inc. and the Registrant dated October 30, 2020
2021-02-2410-K10.7Lease agreement for space at 2615-2629 Douglas Street, Victoria, BC between TC Evolution Limited Partnership and the Registrant dated August 12, 2020
2021-02-2410-K10.6Lease agreement for space at 77 Upper Rock Circle, Rockville, MD between BOF II MD 77 Upper Rock LLC and Aurinia Pharma U.S. Inc. dated March 12, 2020
2021-02-2410-K10.5Manufacturing Services Agreement between the Registrant and Lonza Ltd. dated November 16, 2020
2021-02-2410-K10.1Form of Indemnity Agreement between the Registrant and each of its Directors and Executive Officers

Similar stocks

Stock NameCountryMarket CapPE Ratio
Zai Lab Ltd (ZLAB)$2.241B-113.34
Prestige Consumer Healthcare Inc. (PBH)United States$2.163B13.03
OCULAR THERAPEUTIX, INC (OCUL)United States$2.159B-7.15
Bausch Health Companies Inc. (BHC)$2.113B-1.68
Braveheart Bio, Inc. (BRVE)United States$2.106B
PALVELLA THERAPEUTICS, INC. (PVLA)United States$2.105B-35.55
Trevi Therapeutics, Inc. (TRVI)United States$2.091B-51.93
Viridian Therapeutics, Inc.\DE (VRDN)United States$2.342B-5.38
Mineralys Therapeutics, Inc. (MLYS)United States$2.353B-6.82
Generate Biomedicines, Inc. (GENB)United States$2.052B